Developmental toxicity induced during early stages of mammalian embryogenesis

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 396, Issue 1-2, 1997, Pages 113-127

  Rutledge, Joe C ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Birth defect; Blastocyst; Embryo; Ethylmethane sulfonate; Exencephaly; Hydrops; Implantation; Malformation; Mouse; Mutagen; Mutagenesis; Mutagenicity testing; Omphalocele; Pre gastrulation; Radiation; Retinoic acid; Skeletal defect; Teratogen; Teratogenesis; Zygote

Indexed keywords

AZACITIDINE; CYCLOPHOSPHAMIDE; ETHYLNITROSOUREA; MESYLIC ACID ETHYL ESTER; MESYLIC ACID METHYL ESTER; METHYLNITROSOUREA; MUTAGENIC AGENT; RETINOIC ACID; RETINOL; TERATOGENIC AGENT; TRETAMINE;

CHROMOSOME ABERRATION; CONGENITAL MALFORMATION; EMBRYO DEVELOPMENT; FERTILIZATION; GASTRULATION; GENE EXPRESSION; GENE MUTATION; HUMAN; MOUSE; MUTAGENESIS; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; RAT; REPRODUCTIVE TOXICITY; REVIEW; TERATOGENESIS; ZYGOTE;

EID: 0031565972     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00178-4     Document Type: Article

References (63)

1. Adler I.D., Anderson D., Benigni R., Ehling U.H., Laehdetie J., Pacchierotti F., Russo A., Tates A.D. Synthesis report of the step project detection of germ cell mutagens. Mutation Res. 353:1996;65-84.
2. Rutledge J.C., Kyle J., Cain K., Generoso W.M. Increased incidence of developmental anomalies among descendants of carriers of methylene bisacrylamide-induced balanced reciprocal translocations. Mutation Res. 229:1990;161-172.
3. Katoh M., Cacheiro N.L.A., Cornett C.V., Cain K.T., Rutledge J.C., Generoso W.M. Fetal anomalies produced subsequent to treatment of zygotes with ethylene oxide or ethyl methanesulfonate are not likely due to the usual genetic causes. Mutation Res. 210:1989;337-344.
4. Hale B.F., Crosman K., Robaire B. Increased post-implantation loss and malformations among the F2 progeny of male rats chronically treated with cyclophosphamide. Teratology. 45:1992;671-678.
5. Lyon M.F., Renshaw R. Induction of congenital malformation in mice by parental irradiation: Transmission to later generations. Mutation Res. 198:1988;277-283.
6. Wada A., Sato M., Takashima H., Nagao T. Congenital malformations in the offspring of male mice treated with ethylnitrosourea at the embryonic stage. Teratogen. Carcinogen. Mutagen. 14:1994;271-279.
7. Uh. Ehling, J. Favor, Recessive and dominant mutations in mice: in: E.H.Y. Chu, W.M. Generoso (Eds.), Mutation, Cancer, and Malformation, Plenum Press, New York, 1984, pp. 389-428.
8. Russell L.B., Bangham J.W. The paternal genome in mouse zygotes is less sensitive to ENU mutagenesis than the maternal genome. Mutation Res. 248:1991;203-209.
9. Adler I.D., Cao J., Filser J.G., Gassner P., Kessler W., Kliesch U., Neuhauser-Klaus A., Nusse M. Mutagenicity of 1,3-butadiene inhalation in somatic and germinal cells of mice. Mutation Res. 309:1994;307-314.
10. Ehling U.H. Mutations in the F1 generation of mice. Prog. Clin. Biol. Res. 372:1991;481-496.
11. Favor J., Neuhauser-Klasu A., Ehling U.H. The induction of forward and reverse specific-locus mutations and dominant cataract mutations in spermatogonia of treated strain DBA/2 mice by ethylnitrosourea. Mutation Res. 249:1991;293-300.
12. Sanders D.D., Stephens T.D. Review of drug-induced limb defects in mammals. Teratology. 44:1991;335-354.
13. Generoso W.M., Rutledge J.C., Cain K.T., Hughes L.A., Downing D.J. Mutagen-induced fetal anomalies and death following treatment of females within hours after mating. Mutation Res. 199:1988;175-181.
14. Rutledge J.C., Generoso W.M., Shourbaji A., Cain K.T., Gans M., Oliva J. Developmental anomalies derived from exposure of zygotes and first-cleavage embryos to mutagens. Mutation Res. 296:1992;167-177.
15. Washington W.J., Cain K.T., Cacheiro N.L.A., Generoso W.M. Ethanol-induced late fetal death in mice exposed around the time of fertilization. Mutation Res. 147:1985;205-210.
16. Leach R.E., Stachecki J.J., Armant D.R. Development of in vitro fertilized mouse embryos exposed to ethanol during the pre-implantation period: Accelerated embryogenesis at subtoxic levels. Teratology. 47:1993;57-64.
17. J.C. Rutledge, W.M. Generoso, Malformations in pre-gastrulaton developmental toxicology, in: K. Korach (Ed.), Environmental Chemicals and Early Development, Marcel Dekker, New York, in press.
18. Rutledge J.C., Generoso W.M. Fetal pathology produced by ethylene oxide treatment of murine zygotes. Teratology. 39:1989;563-572.
19. Polifka J.E., Rutledge J.C., Kimmel G.L., Dellarco V., Generoso W.M. Exposure to ethylene oxide during the early zygotic period induces skeletal anomalies in mouse fetuses. Teratology. 53:1996;1-9.
20. Pampfer S., Streffer C. Prenatal death and malformations after irradiation of mouse zygotes with neutrons or X-rays. Teratology. 37:1988;599-607.
21. Hillebrandt S., Streffer C. Protein patterns in tissues of fetuses with radiation-induced gastroschisis. Mutation Res. 308:1994;11-22.
22. Katoh M., Cacheiro N.L.A., Cornett C.V., Cain K.T., Rutledge J.C., Generoso W.M. Fetal anomalies produced subsequent to treatment of zygotes with ethylene oxide or ethylmethane sulfonate are not likely due to the usual genetic causes. Mutation Res. 210:1989;337-344.
23. W.M. Generoso, J.C. Rutledge, J. Aronson, Developmental anomalies: Mutational consequence of mouse zygote exposure, in: Banbury Report 34: Biology of Mammalian Germ Cell Mutagenesis, Cold Spring Harbor Laboratory Press, 1990, pp. 311-319.
24. Weissenborn U., Streffer C. The one-cell mouse embryo: Cell cycle-dependent radiosensitivity and development of chromosomal anomalies in postradiation cell cycles. Int. J. Radiat. 54:1988;659-674.
25. Pampfer S., Mueller W.U., Streffer C. Pre-implantation growth delay and micronucleus formation after in vivo exposure of mouse zygotes to fast neutrons. Radiat. Res. 129:1992;88-95.
26. Pampfer S., Streffer C. Increased chromosome aberration levels in cells from mouse fetuses after zygote X-irradiation. Int. J. Radiat. Biol. 55:1989;85-92.
27. Jacquet P., de Saint-Georges L., Vankerkom J., Baugnet-Mahieu L. Embryonic death, dwarfism and fetal malformations after irradiation of embryos at the zygote stage: Studies on two mouse strains. Mutation Res. 332:1995;73-87.
28. R.S. Dwivedi, P.M. Iannaccone, Effects of environmental chemicals on early development, in: K. Kordach (Ed.), Environmental Chemicals and Early Development, Marcel Dekker, New York, in press.
29. Takeuchi I.K. Teratogenic effects of methylnitrosourea on pregnant mice before implantation. Experientia. 40:1984;879-881.
30. Nagao T., Morita Y., Ishizuka Y., Wada A., Mizutani M. Induction of fetal malformations after treatment of mouse embryos with methylnitrosourea at the preimplantation stages. Teratogen. Carcinogen. Mutagen. 11:1991;1-10.
31. Bossert N.J., Iannaccone P.M. Mid-gestational abnormalities associated with in vitro pre-implantation N-methyl-N-nitrosourea exposure with subsequent transfer to surrogate mothers. Proc. Natl. Acad. Sci. 82:1985;8757-8761.
32. Iannaccone P.M. Long-term effects of exposure to methylnitrosourea on blastocysts following transfer to surrogate female mice. Cancer Res. 44:1984;2785-2789.
33. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 10:1996;940-954.
34. Rutledge J.C., Shourbaji A.G., Hughes L.A., Polifka J.E., Cruz Y.P., Bishop J.B., Generoso W.M. Limb and lower-body duplications induced by retinoic acid in mice. Proc. Natl. Acad. Sci. USA. 91:1994;5436-5440.
35. Shawlot W., Behringer R.R. Requirement for Lim1 in head-organizer function. Nature. 374:1995;425-430.
36. Shenefelt R.E. Morphogenesis of malformations in hamsters caused by retinoic acid: Relation to dose and stage at treatment. Teratology. 5:1972;103-118.
37. Niederreither K., Ward S.J., Doll'e P., Chambon P. Morphological and molecular characterization of retinoic acid-induced limb duplications in mice. Dev. Biol. 176:1996;185-198.
38. Stopper H., Pechan R., Schiffmann D. 5-azacytidine induces micronuclei in and morphological transformation of Syrian hamster embryo fibroblasts in the absence of unscheduled DNA synthesis. Mutation Res. 283:1992;21-28.
39. Dellarco V.L., Shourbaji A.G., Kimmel G.L., Rutledge J.C., Generoso W.M. Fetal anomalies produced from exposure of zygotes or early cleavage embryos to 5-azacytidine. Teratology. 45:1992;504.
40. R.G. Skalko, Cellular mechanisms in teratogenesis, in: T.V.N. Persaud, A.E. Chudley, R.G. Skalko (Eds.), Basic Concepts in Teratology, Alan R. Liss, New York, 1985, pp. 103-118.
41. Olshan A.F., Faustman E.M. Male-mediated developmental toxicity. Annu. Rev. Publ. Health. 14:1993;159-181.
42. Kenney L.B., Nicholson H.S., Brasseux C., Mills J.L., Robison L.L., Zeltzer L.K., Meadows A.T., Reaman G.H., Byrne J. Birth defects in offspring of adult survivors of childhoods acute lymphoblastic leukemia. Cancer. 78:1996;169-176.
43. Siffel C., Czeizel A.E. Study of developmental abnormalities and deaths after human zygote exposure. Mutation Res. 334:1995;293-300.
44. Crosby J.I., Varnum D.S., Washburn L.L., Nadeau J.H. Disorganization is a completely dominant gain-of-function mouse mutation casuing sporadic developmental defects. Mech. Dev. 37:1992;121-126.
45. Winter R.M., Donnai D. A possible human homologue for the mouse mutant disorganisation. J. Med. Genet. 26:1989;417-420.
46. Rutledge J.C., Cain K.T., Hughes L.A., Braden P.W., Generoso W.M. Difference between two hybrid stocks of mice in the incidence of congenital abnormalities following X-ray exposure of stem-cell spermatogonia. Mutation Res. 163:1986;299-302.
47. Kirk K.M., Lyon M.F. Induction of congenital malformations in the offspring of male mice treated with X-rays at pre-meiotic and post-meiotic stages. Mutation Res. 125:1984;75-85.
48. Kirk M., Lyon M.F. Induction of congenital anomalies in offspring of female mice exposed to varying doses of X-rays. Mutation Res. 106:1982;73-83.
49. Nagao T. Congenital defects in the offspring of male mice treated with ethylnitrosourea. Mutation Res. 202:1988;25-33.
50. Nagao T., Fujikawa K. Genotoxic potency in mouse spermatogonial stem cells of triethylenemelamine, mitomycin C, ethylnitrosourea, procarbazine, and propyl methanesulfonate as measured by F1 congenital defects. Mutation Res. 229:1990;123-128.
51. Nomura T. X-ray and chemically induced germ-line mutation causing phenotypical anomalies in mice. Mutation Res. 198:1988;309-320.
52. Trasler J.M., Hales B.F., Robaire B. Paternal cyclophosphamide treatment of rats causes fetal loss and malformations without affecting male fertility. Nature. 316:1985;144-146.
53. Nagao T., Morita Y., Ishizuka Y., Wada A., Mizutani M. Induction of fetal malformations after treatment of mouse embryos with methylnitrosourea at the preimplantation stages. Teratogen. Carcinogen. Mutagen. 11:1991;1-10.
54. Takeuchi I.K. Teratogenic effects of methylnitrosourea on pregnant mice before implantation. Experientia. 40:1984;879-881.
55. Vogel R., Spielmann H. Beneficial effects of ascorbic acid on pre-implantaiton mouse embryos after exposure to cyclophosphamide in vivo. Teratogen. Carcinogen. Mutagen. 9:1989;51-59.
56. Nagao T. Exposure of ethylnitrosourea before implantation induces congenital malformations in mouse fetuses. Cong. Anom. 36:1996;83-94.
57. Pillans P.I., Folb P.I., Ponzi S.F. The effects of in vivo administration of teratogenic doses of vitamin a during the preimplantation period in the mouse. Teratology. 37:1988;7-11.
58. Cummings A.M. Effect of 5-azacytidine administration during very early pregnancy. Fundam. Appl. Toxicol. 23:1994;429-433.
59. LaBorde J.B., Kimmel C.A. The teratogenicity of ethylene oxide administered intravenously to mice. Toxicol. Appl. Pharmacol. 56:1980;16-22.
60. Ohnishi M. Craniofacial malformations induced by N-ethyl-N-nitrosourea in rat embryos in vivo and in vitro. Kobe J. Med. Sci. 35:1989;47-63.
61. Branch S., Francis B.M., Brownie C.F., Chernoff N. Teratogenic effects of the demethylating agent 5-aza-2′-deoxycitidine in the Swiss Webster mouse. Toxicology. 112:1969;37-43.
62. Kochhar D.M., Jiang H., Penner J.D., Heyman R.A. Placental transfer and developmental effects of 9-cis retinoic acid in mice. Teratology. 51:1995;257-265.
63. Jurand A. Action of triethanomelamine (TEM) on early and later stages of mouse embryos. J. Embryol. Exp. Morph. 7:1959;526-539.